OCTREOTIDE FOR INJECTABLE SUSPENSION

Google image searchProduct monograph

Active ingredient

octreotide (octreotide acetate), 20 MG/VIAL

DIN: 02503778

Dosage form(s): POWDER FOR SUSPENSION, SUSTAINED-RELEASE, KIT

Route(s) of administration: INTRAMUSCULAR

Schedule: Prescription

Company: TEVA CANADA LIMITED

Date: 09-AUG-2021

ATC:

Reference brand drug: Sandostatin

Search on Google

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find octreotide for injectable suspension photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.